Once it makes the headline papers like it did, it has touched the ears of Obama administration, SEC,FBI and powerful politicians. Washington Post was the one that printed Watergate and you saw the results.
Adam Feurstein is now finished and Cramer will go into hiding you will see. They went too far.
Hedge Funds and HFT will start covering in the masses as they don't want to be caught with illegal shorting and having been linked to Adam.
Watch as ETRM soars, GREED is now taking over.
Short covering will continue as investors placed wrong bet on OREX which is about to make new lows.
Momemtum investors from OREX, VVUS and ARNA will flock to ETRM.
Enjoy the ride
Frustrated with a stagnant stock that is going no where in the obesity market, better look at ETRM a revolutionary medical device that is about to get FDA Approval and will SOAR.
OREX disappointment going to be making new lows soon due to labeling restrictions and limited revenue opportunity.
Better to take money and switch to ETRM which is about to SOAR on FDA approval of new device. It is trading at a fraction of OREX value.
I agree. That is the reality for now. It will get better and I expect steep rally once we establish a bit of momemtum. The issue is that obesity stocks are out of favor at this moment and, some investors whom put money in ARNA, VVUS and OREX are losing funds so these sell other stocks to compensate like ETRM.
If you concentrate just on valuations, you know darn well that a market cap of $ 85 million for VBLOC which can hit that in sales in one (1) year is very cheap and we should honestly be trading at 10 times this amount.
At some point the buying will start and then it will be non stop for months if not years of great returns.
Lake Street initiated coverage last September 2013 with price target on ETRM of $ 3. Then they came and said 2014 is best idea year for ETRM and raised to $ 4. Now a few months later they reduce price to $ 2.
They appear confused not knowing what price to put on the stock. Hence credibility issues and leading to trader mentality only.
I like better the other analysts whom are firm in their convictions, there are 4 others.
Thanks for making the effort and calling. I personally gave up on calling them as I don't see the point. They are in a quiet period and don't want to showboat themselves off in front of pending FDA approval. I think this is a wise decision as ETRM really has no power over FDA and must comply with them. Knudson has been in the business a long time to know that you don't get into their face especially when you have not hit the targets per protocol and are trying to push it through.
Before you know it, we should have a FDA date and price will firm up.
Notice how only 180,000 shares today on June 19th sent us stock 5 cents. This is real buyers compared to churning of yesterday with 18 million shares and going no where. Longs, put your shares away and let them churn to each other, eventually they go away.